Related Experiment Video
Updated: Dec 10, 2025
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
663
Analysis for 208 children with psoriasis vulgaris
Min Qing1, Panpan Liu2, Wu Zhu2
1Department of Dermatology, Xiangya Hospital, Central South University, Changsha 410008, China. qingmin06@163.com.
Summary
Pediatric psoriasis vulgaris is often triggered by infections and diet. Family history correlates with severe illness, lower quality of life, and metabolic issues like obesity, with low vitamin D levels linked to disease severity.
Area of Science:
- Dermatology
- Pediatrics
- Immunology
Background:
- Psoriasis vulgaris is a chronic inflammatory skin condition affecting children.
- Understanding its characteristics is crucial for effective management.
Purpose of the Study:
- To analyze the clinical features of pediatric psoriasis vulgaris.
- To improve understanding, treatment, and management strategies for children.
Main Methods:
- Retrospective analysis of 208 children with psoriasis vulgaris.
- Evaluation of clinical characteristics, laboratory results, and treatment efficacy.
Main Results:
- Common triggers include infections and diet; family history is linked to increased severity and metabolic abnormalities (overweight/obesity).
- Low serum 25-hydroxyvitamin D (25-OH-VD) levels correlate negatively with Psoriasis Area and Severity Index (PASI) scores.
- Topical treatments and Chinese patent medicines were common; retinoids, cyclosporine, and methotrexate showed efficacy.
Conclusions:
- Infections and diet are key triggers in pediatric psoriasis vulgaris.
- Family history indicates a more severe disease course and higher risk of metabolic issues.
- Serum 25-OH-VD levels are a potential biomarker for disease severity in children.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
01:23Skin Diseases and Disorders
5.0K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.0K
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
108
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
01:35Pedigree Analysis
88.2K
Overview
88.2K
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
168
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
168
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
145
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145